A transformation in neurosurgery
Demonstration of an AI-powered tool during a live surgery at The Neuro
$10 million for Neuro-led project seeking new Alzheimer’s biomarkers
Weston Family Foundation grant will fund the first ultra-high-sensitivity whole body PET/CT scanner in CanadaA groundbreaking project led by Dr. Pedro Rosa-Neto at The Neuro (Montreal Neurological Institute-Hospital) of McGill University has received a major boost thanks to a $10-million grant from the Weston Family Foundation.
Scientists reveal how the brain uses objects to find direction
Study shows how visual landmarks tune the brain’s internal compassWe take our understanding of where we are for granted, until we lose it. When we get lost in nature or a new city, our eyes and brains kick into gear, seeking familiar objects that tell us where we are.
Sylvain Baillet inducted into the Royal Society of Canada
Society recognizes distinguished Canadians who have made remarkable contributions to their academic fields and public lifeSylvain Baillet, PhD, a global leader in brain imaging and systems neuroscience, has been inducted into the Royal Society of Canada, one of the nation’s highest academic honours.
Human instruction with artificial intelligence guidance provided best results in neurosurgical training
Study has implications beyond medical education, suggesting other fields could benefit from AI-enhanced training
Artificial intelligence (AI) is becoming a powerful new tool in training and education, including in the field of neurosurgery. Yet a new study suggests that AI tutoring provides better results when paired with human instruction.
HBHL Scientific Director Alan Evans receives Order of Canada
Original article by The Neuro.
Career of breakthroughs in neuroimaging recognized with one of the nation’s highest honoursA career that took an uncharted trajectory has been recognized with the Order of Canada, one of the country’s top honours.
Alan Evans receives Order of Canada
Career of breakthroughs in neuroimaging recognized with one of the nation’s highest honoursA career that took an uncharted trajectory has been recognized with the Order of Canada, one of the country’s top honours.
AI analysis of healthcare records reveals key factors in autism diagnosis
Scientists argue the criteria we use for diagnosing autism may need revisionWithout clear and effective biological tests for autism based on genes, brain or blood measurements, diagnosis today still largely depends on clinical assessment. The standard way of doing this is by observing how the individual fits the criteria for autism listed in gold standard manuals like the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5).
Latest Alzheimer’s drug shown less effective in females than males
Since becoming only the second Alzheimer’s-modifying drug to gain American FDA approval in 2023, sales of lecanemab, known by its brand name Leqembi, have risen steadily, reaching $87-million USD in the last quarter of 2024.
Project to create AI model for ALS receives Génome Québec funding
$400,000 will fuel public-private collaboration to discover new disease biomarkers
Prescribing anti-swelling drug reduces immune response weeks after last dose
Mapping immune cell diversity reveals dexamethasone’s impact on brain cancer immunotherapy
Swelling caused by brain cancer is a problem that can lead to serious side effects and even death. While controlling swelling is important, a new study shows that a commonly prescribed anti-swelling drug suppresses the immune system for weeks after dosage, inhibiting the body’s ability to fight the cancer.
Six principal investigators from The Neuro receive CIHR grants
Projects include important research on Parkinson’s, glioblastoma and dementia
An open solution to improving research reproducibility
Academic and industry scientists collaborate on a new method to characterize research antibodiesStructural Genomics Consortium researchers at The Neuro (Montreal Neurological Institute-Hospital) of McGill University, in collaboration with scientists from 11 major antibody manufacturers representing approximately 80 per cent of global renewable antibody production, have developed and standardized an Open Science platform to characterize research antibodies.
At-home neurological disorder diagnosis project receives major funding
$1M grant from The Weston Family Foundation will pave the way for earlier intervention in REM sleep behaviour disorder and Parkinson’s diseaseREM sleep behaviour disorder (RBD) is an often debilitating condition that causes people to act out in their sleep, sometimes violently. What’s worse, people with the disorder often go on to develop Parkinson’s disease.
Research on new stem cell models receives $2.6 million
Thomas Durcan’s project will dissect the role of microglia in degenerative conditions, to identify new therapeutic strategies for Alzheimer's treatmentAn innovative new program based at The Neuro has received $2.6 million from the CQDM and the Brain Canada Foundation.